Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation June 2014.

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

Aug 28, 2014
SciClone and BTG Announce That DC Bead(R) Has Been Approved by China Food and Drug Administration

Aug 11, 2014
SciClone Reports Financial Results for the Second Quarter 2014

View all releases »

Events & Presentations

Aug 11, 2014 at 4:30 PM ET
Q2 2014 SciClone Pharmaceuticals, Inc. Earnings

Jun 3, 2014 at 9:00 AM ET
Jefferies 2014 Global Healthcare Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 6.86
Change: + 0.23
Day High: 6.96
Day Low: 6.58
Volume: 553,800
Delayed at least 20 minutes.
Provided by eSignal.